Wright Investors Service Inc Abb Vie Inc. Transaction History

Wright Investors Service Inc

$377 Million
Q3 2024

A detailed history of Wright Investors Service Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wright Investors Service Inc holds 48,526 shares of ABBV stock, worth $8.51 Million. This represents 2.54% of its overall portfolio holdings.

Number of Shares

48,526

Previous 44,646 8.69%

Holding current value

$8.51 Million

Previous $7.66 Million 25.14%

% of portfolio

2.54%

Previous 2.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$163.84 - $199.33 $635,699 - $773,400	3,880 Added 8.69%	48,526 $9.58 Million
Q2 2024 Jul 26, 2024	SELL	$154.79 - $180.76 $896,698 - $1.05 Million	-5,793 Reduced 11.49%	44,646 $7.66 Million
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $665,969 - $758,810	4,167 Added 9.01%	50,439 $9.18 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $885,868 - $997,696	6,438 Added 16.16%	46,272 $7.17 Million
Q3 2023 Oct 31, 2023	BUY	$133.59 - $154.65 $77,081 - $89,233	577 Added 1.47%	39,834 $5.94 Million
Q2 2023 Jul 27, 2023	SELL	$132.51 - $164.9 $342,008 - $425,606	-2,581 Reduced 6.17%	39,257 $5.29 Million
Q1 2023 Apr 26, 2023	SELL	$144.61 - $166.54 $7,808 - $8,993	-54 Reduced 0.13%	41,838 $6.67 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $1.52 Million - $1.82 Million	-10,996 Reduced 20.79%	41,892 $0
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $164,541 - $188,718	-1,226 Reduced 2.27%	52,888 $7.1 Million
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $1.65 Million - $2.1 Million	11,989 Added 28.46%	54,114 $8.29 Million
Q1 2022 Apr 22, 2022	BUY	$131.98 - $163.75 $69,553 - $86,296	527 Added 1.27%	42,125 $6.83 Million
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $266,856 - $337,650	2,484 Added 6.35%	41,598 $5.63 Million
Q3 2021 Nov 01, 2021	SELL	$106.4 - $120.78 $372,719 - $423,092	-3,503 Reduced 8.22%	39,114 $4.22 Million
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $801,805 - $893,257	7,621 Added 21.78%	42,617 $4.8 Million
Q1 2021 Apr 29, 2021	SELL	$102.3 - $112.62 $614,925 - $676,958	-6,011 Reduced 14.66%	34,996 $3.79 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $594,821 - $803,071	-7,390 Reduced 15.27%	41,007 $4.39 Million
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $203,348 - $238,664	-2,367 Reduced 4.66%	48,397 $4.24 Million
Q2 2020 Jul 23, 2020	SELL	$73.37 - $98.18 $409,477 - $547,942	-5,581 Reduced 9.91%	50,764 $4.98 Million
Q1 2020 Apr 30, 2020	SELL	$64.5 - $97.79 $258,129 - $391,355	-4,002 Reduced 6.63%	56,345 $4.29 Million
Q4 2019 Jan 28, 2020	SELL	$72.13 - $90.25 $128,391 - $160,645	-1,780 Reduced 2.87%	60,347 $5.34 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $2.12 Million - $2.55 Million	33,689 Added 118.46%	62,127 $4.7 Million
Q2 2019 Aug 01, 2019	SELL	$65.7 - $83.98 $348,012 - $444,842	-5,297 Reduced 15.7%	28,438 $2.07 Million
Q1 2019 Apr 24, 2019	SELL	$77.14 - $90.79 $287,269 - $338,101	-3,724 Reduced 9.94%	33,735 $2.72 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $580,527 - $715,946	-7,457 Reduced 16.6%	37,459 $3.45 Million
Q3 2018 Oct 25, 2018	SELL	$88.91 - $98.84 $8,446 - $9,389	-95 Reduced 0.21%	44,916 $4.25 Million
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $378,961 - $448,396	-4,221 Reduced 8.57%	45,011 $4.17 Million
Q1 2018 Apr 25, 2018	SELL	$92.01 - $123.21 $498,786 - $667,921	-5,421 Reduced 9.92%	49,232 $4.66 Million
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $350,000 - $383,804	3,908 Added 7.7%	54,653 $5.29 Million
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $3.54 Million - $4.53 Million	50,745	50,745 $4.51 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wright Investors Service Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wright Investors Service Inc with notifications on news.

Account

Wright Investors Service Inc Abb Vie Inc. Transaction History